Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Investing

Merck : MRK

All Merck Articles

1088 Articles

Jon C. Ogg | Oct 30, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Monday include AMD, Chevron, GM, Intel, Merck, Nokia and Under…

Chris Lange | Oct 27, 2017 at 8:50 AM EDT

Merck Earnings Fall Short Despite Incredible Keytruda Sales

Pharma giant Merck reported mixed third-quarter financial results before the markets opened on Friday.

Chris Lange | Oct 25, 2017 at 10:20 AM EDT

Short Sellers Hike Bets in Major Pharma

The October 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 22, 2017 at 10:35 AM EDT

Boeing, McDonald’s, Intel and More Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of Boeing, McDonald's, Intel and other top Dow Jones Industrial Average companies…

Lee Jackson | Oct 19, 2017 at 8:30 AM EDT

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

These four top companies all have data that could move the shares the rest of this year and into 2018.…

Jon C. Ogg | Oct 18, 2017 at 9:15 AM EDT

Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa, Zynga and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Chevron, Chipotle Mexican Grill, Exxon Mobil, Goldman Sachs,…

Chris Lange | Oct 11, 2017 at 10:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 29 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Oct 3, 2017 at 10:55 AM EDT

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of…

Paul Ausick | Sep 29, 2017 at 4:01 PM EDT

Nike, Merck Weigh on DJIA Friday

The Dow Jones Industrial Average closed essentially flat on Friday, with Nike and Merck posting the largest losses and Goldman…

Chris Lange | Sep 27, 2017 at 9:00 AM EDT

Major Pharma Short Interest Piles On

The September 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 26, 2017 at 12:10 PM EDT

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech…

Paul Ausick | Sep 22, 2017 at 4:01 PM EDT

Apple, UnitedHealth Weigh on DJIA Friday

Apple, UnitedHealth, Walmart, and Merck led the losers among the Dow 30 stocks on Friday.

Paul Ausick | Sep 14, 2017 at 4:01 PM EDT

United Technologies, Pfizer Lead DJIA Higher on Thursday

United Technologies, Pfizer, Merck, and Boeing were the stalwarts among the DJIA index stocks on Thursday.

Chris Lange | Sep 14, 2017 at 1:35 PM EDT

Why Pfizer Is Pushing the Dow to All-Time Highs

Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on…

Chris Lange | Sep 13, 2017 at 8:40 AM EDT

Major Pharma Short Interest Surges

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 27 28 29 30 31 … 73

Merck : MRK

All Merck Articles

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

Merck Earnings Fall Short Despite Incredible Keytruda Sales

Short Sellers Hike Bets in Major Pharma

Boeing, McDonald’s, Intel and More Dow Earnings Coming This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa, Zynga and More

Short Sellers Run for Cover From Major Pharma

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

Nike, Merck Weigh on DJIA Friday

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

Apple, UnitedHealth Weigh on DJIA Friday

United Technologies, Pfizer Lead DJIA Higher on Thursday

Why Pfizer Is Pushing the Dow to All-Time Highs

Major Pharma Short Interest Surges

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

VEA Is Crushing SPY This Year, but the Decade-Long Scorecard Tells a Different Story

Tesla Is $370: Should You Buy?

SK Hynix Rockets 14% Ahead of July 29 Earnings as Chip Stocks Rebound

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.

VEA Is Crushing SPY This Year, but the Decade-Long Scorecard Tells a Different Story

Tesla Is $370: Should You Buy?

Merck : MRK

All Merck Articles

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

Merck Earnings Fall Short Despite Incredible Keytruda Sales

Short Sellers Hike Bets in Major Pharma

Boeing, McDonald’s, Intel and More Dow Earnings Coming This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa, Zynga and More

Short Sellers Run for Cover From Major Pharma

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

Nike, Merck Weigh on DJIA Friday

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

Apple, UnitedHealth Weigh on DJIA Friday

United Technologies, Pfizer Lead DJIA Higher on Thursday

Why Pfizer Is Pushing the Dow to All-Time Highs

Major Pharma Short Interest Surges

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

VEA Is Crushing SPY This Year, but the Decade-Long Scorecard Tells a Different Story

Tesla Is $370: Should You Buy?

SK Hynix Rockets 14% Ahead of July 29 Earnings as Chip Stocks Rebound

Featured Reads

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.